首页|期刊导航|Oncology Research|Put the CAR-T before the HRS:Advances in Anti-CD30 Immunotherapy Targeting Hodgkin/Reed-Sternberg Cells in Classical Hodgkin Lymphoma
Put the CAR-T before the HRS:Advances in Anti-CD30 Immunotherapy Targeting Hodgkin/Reed-Sternberg Cells in Classical Hodgkin Lymphoma
Yuriy Mayasin Maria Osinnikova Daria Osadchaya Victoria Dmitrienko Anna Gorodilova Chulpan Kharisova Kristina Kitaeva Valeria Solovyeva Albert Rizvanov
Oncology Research2026,Vol.34Issue(3):P.248-294,47.
Oncology Research2026,Vol.34Issue(3):P.248-294,47.DOI:10.32604/or.2025.073008
Put the CAR-T before the HRS:Advances in Anti-CD30 Immunotherapy Targeting Hodgkin/Reed-Sternberg Cells in Classical Hodgkin Lymphoma
摘要
关键词
Hodgkin lymphoma/chimeric antigen receptor T cells/immunotherapy/monoclonal antibodies/Hodgkin/reed-Sternberg cells/clinical trials分类
医药卫生引用本文复制引用
Yuriy Mayasin,Maria Osinnikova,Daria Osadchaya,Victoria Dmitrienko,Anna Gorodilova,Chulpan Kharisova,Kristina Kitaeva,Valeria Solovyeva,Albert Rizvanov..Put the CAR-T before the HRS:Advances in Anti-CD30 Immunotherapy Targeting Hodgkin/Reed-Sternberg Cells in Classical Hodgkin Lymphoma[J].Oncology Research,2026,34(3):P.248-294,47.基金项目
supported by the Kazan Federal University Strategic Academic Leadership Program(PRIORITY-2030). (PRIORITY-2030)